DOSSIERS / GENESIS PHARMA (CYPRUS) LIMITED
← SearchExport PDF
Company dossier

GENESIS PHARMA (CYPRUS) LIMITED

CYPRUS · COMPANY · INCORPORATED 1999-12-27
KYBE ID: HE107632 · HE107632 · 2 sources
RISK SCORE54HIGH RISK

Key facts

active
GENESIS PHARMA (CYPRUS) LIMITED
DRCIP data.gov.cy
HE107632
DRCIP data.gov.cy
active
DRCIP data.gov.cy
Private Company
DRCIP data.gov.cy
1999-12-27
DRCIP data.gov.cy
Μετοχίου, 73,, CONSULCO BUILDING, Floor 3,, 'Εγκωμη, 2407, Λευκωσία, Κύπρος
DRCIP data.gov.cy

Companies at this address

292 total

Connections

4 links
Shared operator — likely the same administrator
ΑGROLAN LIMITEDShared officer / director · 5 share thisΜ. Σ. ΙΑΚΩΒΙΔΗΣ & ΣΙΑ ΛΙΜΙΤΕΔShared officer / director · 5 share thisLIFEPHARMA (Z.A.M.) LIMITEDShared officer / director · 5 share thisCYGEN LIMITEDShared officer / director · 5 share this

A shared address, domain or mail server is a lead, not a verdict — most often the same administrator (accountant / corporate-services provider), not a single group.

People with significant control

5 people
NameRoleFromSource
ΑΛΕΞΑΝΔΡΟΣ ΙΑΚΩΒΙΔΗΣdirectorCyprus registry
ΑΡΙΣΤΟΚΛΗΣ ΙΑΚΩΒΙΔΗΣdirectorCyprus registry
ΚΩΝΣΤΑΝΤΙΝΟΣ ΕΥΡΙΠΙΔΗΣdirectorCyprus registry
ΣΩΤΗΡΙΟΣ ΙΑΚΩΒΙΔΗΣdirectorCyprus registry
ΑΝΤΩΝΗΣ ΛΟΥΡΟΥΤΖΙΑΤΗΣsecretaryCyprus registry

Risk signals

3 matched
high

Mass-registration address

Registered address shared by 292 companies — letterbox / formation-agent

high

Single-bidder procurement pattern

11 of 12 public-tender wins had only ONE bidder (92%) — the classic bid-rigging / suppressed-competition signal

high

Business fragmentation

A director is shared across 21 companies — business-splitting (дробление) pattern

Risk journey — why 54?

3 signals
+22
Mass-registration address
+16
Single-bidder procurement pattern
+16
Business fragmentation
Composite risk score54/100